Stereotaxis

Stereotaxis, founded in 1990, is a global leader in robotic technologies for electrophysiology innovation, dedicated to providing robotic systems and integrated solutions for interventional catheter labs applicable to electrophysiology and other interventional procedures. It helps physicians deliver surgical treatments with higher precision and safety for patients, improves the efficiency of catheter lab procedures, and enhances the integration of procedural information. In 2003, Stereotaxis launched the world's first magnetic navigation electrophysiology robot, Niobe®. The upgraded Genesis RMN® system received FDA approval for marketing in the United States in 2020. The core components of the electrophysiology robotic system developed by Stereotaxis have also gained registration approvals in China, Japan, the European Union, Canada, and other countries and regions.